|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-9-28
|
|
pubmed:abstractText |
To formulate individually tailored therapy for patients with early-stage breast cancer, it is necessary to identify biomarkers for predicting metastasis and survival.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/BIRC5 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Inhibitor of Apoptosis Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/MET protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Microtubule-Associated Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-met,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/S100 Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/S100A4 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0030-2414
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2004 S. Karger AG, Basel
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
66
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
429-38
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15452371-Adult,
pubmed-meshheading:15452371-Aged,
pubmed-meshheading:15452371-Breast Neoplasms,
pubmed-meshheading:15452371-Carcinoma,
pubmed-meshheading:15452371-Disease-Free Survival,
pubmed-meshheading:15452371-Female,
pubmed-meshheading:15452371-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:15452371-Humans,
pubmed-meshheading:15452371-Immunohistochemistry,
pubmed-meshheading:15452371-Inhibitor of Apoptosis Proteins,
pubmed-meshheading:15452371-Microtubule-Associated Proteins,
pubmed-meshheading:15452371-Middle Aged,
pubmed-meshheading:15452371-Multivariate Analysis,
pubmed-meshheading:15452371-Neoplasm Proteins,
pubmed-meshheading:15452371-Neoplasm Staging,
pubmed-meshheading:15452371-Odds Ratio,
pubmed-meshheading:15452371-Predictive Value of Tests,
pubmed-meshheading:15452371-Prognosis,
pubmed-meshheading:15452371-Proportional Hazards Models,
pubmed-meshheading:15452371-Proteins,
pubmed-meshheading:15452371-Proto-Oncogene Proteins,
pubmed-meshheading:15452371-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:15452371-Proto-Oncogene Proteins c-met,
pubmed-meshheading:15452371-Receptor, erbB-2,
pubmed-meshheading:15452371-Receptors, Growth Factor,
pubmed-meshheading:15452371-Risk Assessment,
pubmed-meshheading:15452371-Risk Factors,
pubmed-meshheading:15452371-S100 Proteins,
pubmed-meshheading:15452371-Tumor Markers, Biological,
pubmed-meshheading:15452371-Tumor Suppressor Protein p53
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
|
|
pubmed:affiliation |
Department of Pathology, National Cheng Kung University Hospital, Tainan, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
